Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges
| Заболевание | Alzheimer Disease, Mild Cognitive Impairment, Dementia |
|---|---|
| Фаза | Не применимо |
| Спонсор | Brigham and Women's Hospital |
| Статус | Завершено |
| Участники | 262 участн. |
| Вмешательство | Nudge Intervention |
| Дата начала | 1.08.2024 |
| Дата завершения | 14.10.2025 |
| Публикация результатов | 30.07.2026 |
Кратко
The objectives of this study are to demonstrate the feasibility of implementing a deprescribing nudge intervention using pragmatic methods, confirm that outcomes can be feasibly measured and evaluated at scale in a subsequent embedded pragmatic clinical trial (ePCT), and explore representativeness of persons living with dementia and care partners identified.
Composite of the Percentage of Eligible PCPs or Their PLWD/Care Partners Who View or Click on Information on or Before the Primary Care Provider Visit, up to 10 Days
| Nudge Intervention | 103 Participants |
|---|
Открыть в BENITIONS Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
- Technology and Family Thriving Study — University of California, Santa Barbara
- Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University